Glucose Tolerance Test Market Size in 2022, Share, Revenue, Future Demands, SWOT analysis, Forecast to 2028

A Glucose Tolerance Test measures how well a body’s cells is capable to engross glucose, or sugar, after a patient consume a given amount of sugar.Report OverviewDue to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Glucose Tolerance Test estimated at USD 29600 million in the year 2022, is projected to reach a revised size of USD 41750 million by 2028, growing at a CAGR of 5.9% during the forecast period 2022-2028.The USA market for Glucose Tolerance Test is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The China market for Glucose Tolerance Test is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The Europe market for Glucose Tolerance Test is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The global key companies of Glucose Tolerance Test include Abbott Laboratories, Roche, Medtronic, Panasonic, Sanofi, Dexcom and LifeScan, etc. In 2021, the global top five players had a share approximately percent in terms of revenue.